Assessing Research Benefits

Posted on Aug 9th, 2017

Authors: Jeffrey Cooper, MD, MMM Vice President, Process and Strategic Improvement WIRB-Copernicus Group  Lindsay McNair, MD, MPH,…

Continue Reading

Myths and Realities of Placebo Response: A 21st Century Prescription

Posted on Jun 29th, 2017

Author: Mark Opler, PhD, MPH Chief Scientific Officer ProPhase Publication: Clinical…

Continue Reading

Applying ISO 9001 to the IRB Process

Posted on Jun 29th, 2017

Authors: David Borasky, MPH, CIP Vice President, Quality Management WIRB-Copernicus Group Heather Kim, MS, RAC, CIP Quality Assurance…

Continue Reading

Message from the Guest Editor

Posted on Jun 29th, 2017

Author: Jeffrey A. Cooper, MD, MMM Vice President for Process and Strategic Improvement WIRB-Copernicus Group (WCG) Publication: Clinical…

Continue Reading

Future World Without Paper Consent Could Be Here Sooner Than Imagined

Posted on Jun 28th, 2017

Authors: David Forster, JD, MA, CIP Chief Compliance Officer WIRB-Copernicus Group (WCG) Publication: IRB…

Continue Reading

The Clinical Trials Technology Ecosystem

Posted on Jun 28th, 2017

Authors: Suzanne Caruso VP, Clinical Solutions WIRB-Copernicus Group (WCG) Dawn Furey Executive Director and Head of Global Clinical Trial…

Continue Reading

Three Tips for Reaching Your Study Enrollment Goals

Posted on Jun 28th, 2017

Author: Suzanne Caruso VP, Clinical Solutions WIRB-Copernicus Group…

Continue Reading

Syncing The Unsyncable: Legal and Policy Implications of Paperless Clinical Trials

Posted on May 10th, 2017

Author: Kimberly Rhodes Chief Legal Officer WIRB-Copernicus Group Publication: Hastings Science & Technology Law Journal, Volume 9, Number 2,…

Continue Reading

Envisioning the site of the future

Posted on May 3rd, 2017

Author: Karyn Korieth Journalist CenterWatch Publication: The CenterWatch…

Continue Reading

Equitable Selection of Subjects: Equality Versus Fairness?

Posted on Apr 12th, 2017

Authors: Jeffrey Cooper, MD, MMM Vice President, Process & Strategic Improvement WIRB-Copernicus Group (WCG) Lindsay McNair, MD, MPH,…

Continue Reading

Final Common Rule Emerges After Six Years, Omitting Most Controversial Ideas

Posted on Feb 8th, 2017

Publication: Report on Research Compliance, Volume 14, Number 2, February 2017 issue Featuring: David Borasky, MPH, CIP Vice President, Quality…

Continue Reading

To What Extent Do Risks Need to Be Minimized?

Posted on Jan 11th, 2017

Authors: Jeffrey Cooper, MD, MMM Vice President, Process & Strategic Improvement WIRB-Copernicus Group (WCG) Lindsay McNair, MD, MPH,…

Continue Reading

Data-driven Site Selection: Accelerating Your Trials Through Predictive Site Modeling

Posted on Nov 30th, 2016

Author: Suzanne Caruso VP, Clinical Solutions WIRB-Copernicus Group…

Continue Reading

Sites rate their relationships with IRBs

Posted on Nov 8th, 2016

WCG’s Chief Growth Officer and Executive Vice President, Nicholas Slack, MBE, is featured in the recent article, “Sites rate their relationships…

Continue Reading

Getting the Right Signatures on Informed Consent Documents

Posted on Oct 26th, 2016

WCG’s Chief Medical Officer, Lindsay McNair, MD, MPH, MSBioethics, Copernicus Group IRB's IRB Board Vice Chair, Patience Stevens, MD, MPH, CIP, and…

Continue Reading

WCG Foundation Launches to Spur Global Clinical Research

Posted on Dec 9th, 2015

WCG’s Chairman & CEO, Donald A. Deieso, PhD, and WCG Foundation's Executive Director, Marjorie A. Speers, PhD are interviewed by DDNews' Lloyd…

Continue Reading

Integrated Study-specific eClinical Solutions: The Most Efficient Path Forward and Highest Quality Results

Posted on Nov 30th, 2015

WCG’s Vice President, Clinical Solutions, Suzanne Caruso authors "Integrated Study-specific eClinical Solutions: The Most Efficient Path Forward…

Continue Reading

Executive Viewpoints

Posted on Nov 30th, 2015

WCG’s Vice President, Clinical Solutions, Suzanne Caruso provides perspective on interoperability and transparency advantages for the PharmaVOICE…

Continue Reading

How Precision Medicine is Impacting R&D Strategies

Posted on Nov 30th, 2015

WCG’s Chief Medical Officer, Lindsay McNair, MD, MPH, MSBioethics provides perspective on precision medicine for the PharmaVOICE "Year in Preview"…

Continue Reading

Exclusions and Exemptions: Will New Tool, Revised Common Rule Make These Clear?

Posted on Nov 30th, 2016

Copernicus Group IRB’s Vice President, Quality Management, David Borasky, MPH, CIP is interviewed by Report on Research Compliance’s Theresa…

Continue Reading

WCG Foundation to Offer Ethics Training, Education

Posted on Nov 23rd, 2015

WCG Foundation's Executive Director, Marjorie A. Speers, PhD is interviewed by CenterWatch Weekly's Ron Rosenberg. Publication: CenterWatch…

Continue Reading

How to Increase Patient Enrollment by 600%

Posted on Nov 19th, 2015

This article is based on ePharmaSolutions' Senior Vice President, Lisa La Luna's presentation at the 2015 Patients as Partners…

Continue Reading

US Plans to Require Trial Consent Publication

Posted on Nov 18th, 2015

Copernicus Group IRB’s Vice President, Quality Management, David Borasky, MPH, CIP is interviewed by Outsourcing-Pharma.com's Fiona…

Continue Reading

Will NPRM Changes Affect Your Clinical Trials?

Posted on Nov 17th, 2015

WCG’s Chief Compliance Officer, David Forster, JD, MA, CIP and Copernicus Group IRB’s Vice President, Quality Management, David Borasky, MPH, CIP…

Continue Reading

Draft Guidance on Recording IRB Activities Unveiled

Posted on Nov 16th, 2015

Copernicus Group IRB’s Vice President, Quality Management, David Borasky, MPH, CIP is interviewed by CenterWatch Weekly's Ron…

Continue Reading

WIRB-Copernicus Group Launches Nonprofit WCG Foundation to Improve Global Clinical Research

Posted on Nov 12th, 2015

WIRB-Copernicus Group (WCG) announces the launch of WCG Foundation. WCG Foundation is the first 501(c)(3) public charity founded by an independent…

Continue Reading

A Look at What’s Not in The NPRM

Posted on Oct 30th, 2015

WCG’s Chief Compliance Officer, David Forster, JD, MA, CIP and Copernicus Group IRB's Vice President, Quality Management, David Borasky, MPH, CIP…

Continue Reading

Groups Offer NPRM Help; OHRP Promises Town Hall This Month

Posted on Oct 30th, 2015

WCG’s Chief Compliance Officer, David Forster, JD, MA, CIP and Copernicus Group IRB's Vice President, Quality Management, David Borasky, MPH, CIP…

Continue Reading

Proposed HHS Rule Changes Cause IRB Concerns

Posted on Oct 26th, 2015

WCG’s Chief Compliance Officer, David Forster, JD, MA, CIP is interviewed by CenterWatch Weekly's Ron Rosenberg. Publication: CenterWatch…

Continue Reading

Changes Ahead for Informed Consent, IRBs, Transparency

Posted on Oct 1st, 2015

WCG’s Chief Compliance Officer, David Forster, JD, MA, CIP is interviewed by Applied Clinical Trials' Jill Wechsler. Publication: Applied…

Continue Reading

WIRB-Copernicus Group and the Prostate Cancer Clinical Trials Consortium Announce New Partnership to Improve Efficiency of Oncology Research Reviews

Posted on Sep 29th, 2015

WIRB-Copernicus Group (WCG) and Prostate Cancer Clinical Trials Consortium (PCCTC) announced their new partnership to enhance the quality and…

Continue Reading

How Social Media Might Be Sabotaging Your Clinical Trial

Posted on Sep 1st, 2015

Publication: Life Science Leader To read this article based on Dr. Lindsay McNair’s presentation at the 2015 DIA Annual Meeting, please click…

Continue Reading

Human Gene Transfer Research: What Clinical Research Professionals Need to Know

Posted on Aug 27th, 2015

WCG’s Chief Medical Officer Lindsay McNair, MD, MPH, MSBioethics and Chris Jenkins, PhD, MPH, RBP, CHMM, authors “Human Gene Transfer Research:…

Continue Reading

Lead Story: Bioethicists Warn of Harm in “Pay-to-Play” Trials

Posted on Aug 17th, 2015

WCG’s Chief Medical Officer, Lindsay McNair, MD, MPH, MSBioethics and NYU Langone's  Head, Division of Bioethics, Arthur Caplan, PhD…

Continue Reading

DIA 2015: Editor’s Take

Posted on Jul 29th, 2015

PharmaVOICE interviews WCG's Chairman & CEO, Donald A. Deieso, PhD for the DIA 2015 "Editor's Take" Video. Publication: PharmaVOICE To…

Continue Reading

Managing the Scientific and Ethical Complexities of Medical Innovation

Posted on Jun 25th, 2015

WCG’s Chief Medical Officer Lindsay McNair, MD, MPH, MSBioethics authors "Managing the Scientific and Ethical Complexities of Medical Innovation"…

Continue Reading

Classifying Clinical Trial Portals

Posted on Jun 25th, 2015

ePharmaSolutions' Lance Converse is interviewed by CenterWatch Monthly. Publication: CenterWatch…

Continue Reading

Can Facebook Hurt Your Clinical Trial?

Posted on Jun 22nd, 2015

Publication: Applied Clinical Trials To read this article based on Dr. Lindsay McNair's presentation at the 2015 DIA Annual Meeting, please click…

Continue Reading

WIRB-Copernicus Group Expands Its Annual International Fellows Program To Include Ethics Training At New York University Langone Medical Center

Posted on Jun 19th, 2015

The 13th annual WCG International Fellows Program in Research Ethics will include ethics training at New York University (NYU) Langone Medical…

Continue Reading

Executive Viewpoints

Posted on Jun 1st, 2015

WCG’s Chief Medical Officer, Lindsay McNair, MD, MPH, MSBioethics, is interviewed by PharmaVOICE to discuss perspectives on recombinant DNA and…

Continue Reading

Patients’ Increased Sharing of Clinical Trial Experience Through Social Media Can Help Sponsors Improve Outcomes, Enrollment

Posted on Jun 1st, 2015

Publication: Research Practitioner Interview With: Lindsay McNair, MD, MPH, MSBioethics; WCG's Chief Medical…

Continue Reading

ResearchKit Apps

Posted on May 28th, 2015

Publication: IRB Advisor Interview with: David Forster, JD, MA, CIP; WCG's Chief Compliance…

Continue Reading

Job Satisfaction Mixed as Workload Increases

Posted on May 28th, 2015

WCG’s Senior Vice President, Human Resources & Administration, Meghan Weiss, is interviewed by CenterWatch Monthly's Karyn…

Continue Reading

WCG, Certara Co-Sponsor Lasker Lessons in Leadership Events

Posted on May 20th, 2015

Publication: CenterWatch News Online To read this article, please click…

Continue Reading

New England IRB Awarded AAHRPP Reaccreditation

Posted on May 11th, 2015

New England Institutional Review Board (IRB) has been reaccredited by the Association for the Accreditation of Human Research Protection Programs…

Continue Reading

Global IRB WIRB-Copernicus Group (WCG) Will Encourage the 1,200 Members of its Global Research Network to Accept and Use the Accelerated Clinical Trial Agreement

Posted on Apr 27th, 2015

WCG’s President of Institutions & Institutional Services, Stuart Horowitz, PhD, MBA, discusses the encouragement of the Accelerated Clinical…

Continue Reading

WIRB-Copernicus Group Supports Accelerated Clinical Trial Agreement by WCG Global Research Network

Posted on Apr 20th, 2015

WCG will encourage members of its Global Research Network (GRN) to accept the Accelerated Clinical Trial Agreement (ACTA) as their default agreement…

Continue Reading

WCG calls on 1200 member institutions to adopt Accelerated Clinical Trial Agreement

Posted on Apr 20th, 2015

WCG's President of Institutions & Institutional Services, Stuart Horowitz, PhD, MBA, discusses the encouragement of the Accelerated Clinical Trial…

Continue Reading

WCG encourages its global research network to use ACTA as clinical trial contract solution

Posted on Apr 20th, 2015

WCG's President of Institutions & Institutional Services, Stuart Horowitz, PhD, MBA, discusses WCG's support of the Accelerated Clinical Trial…

Continue Reading

Slow study start-ups tied to local IRB use, expert says

Posted on Mar 31st, 2015

WCG's Chief Medical Officer and President of Consulting Services, Lindsay McNair, MD, MPH, MSBioethics, discusses time savings associated with the…

Continue Reading

Standing Up For Human Test Subjects

Posted on Mar 25th, 2015

U.S. 1 News, Princeton, New Jersey's local newspaper, featured WIRB-Copernicus Group (WCG) as the cover story of its March 25, 2015 issue. The U.S. 1…

Continue Reading

Western Institutional Review Board receives ISO 9001:2008 certification

Posted on Mar 17th, 2015

WIRB-Copernicus Group has announced that Western Institutional Review Board (WIRB) has been certified to ISO 9001:2008 by BSI, confirming it operates…

Continue Reading

US FDA offers draft guidance on electronic informed consent

Posted on Mar 11th, 2015

Lindsay McNair, MD, MPH, MSB, Chief Medical Officer & President, Consulting Services for the WIRB-Copernicus Group (WCG) was interviewed by…

Continue Reading

Patients’ increased sharing of clinical trial experiences through social media can help sponsors improve outcomes, enrollment

Posted on Mar 3rd, 2015

Lindsay McNair, MD, MPH, MSB, Chief Medical Officer & President, Consulting Services for the WIRB-Copernicus Group (WCG) was interviewed by…

Continue Reading

WIRB-Copernicus Group’s Dr. Stuart Horowitz Has Been Appointed to the Association of Clinical Research Professionals’ Editorial Advisory Board

Posted on Mar 3rd, 2015

Stuart Horowitz, PhD, MBA, President of Institutions & Institutional Services of the WIRB-Copernicus Group, has been appointed to the Association…

Continue Reading

CTCA Selects WIRB-Copernicus Group to Expand its Clinical Research Programme

Posted on Dec 17th, 2014

Publication: PHARMABIZ.com To read this article, please click…

Continue Reading

Cancer Treatment Centers of America Selects WIRB-Copernicus Group to Facilitate the Expansion of its Clinical Research Program

Posted on Dec 15th, 2014

Publication: Clinical Informatics News To read this article, please click…

Continue Reading

Cancer Treatment Centers of America Selects WIRB-Copernicus Group

Posted on Dec 15th, 2014

WIRB-Copernicus Group (WCG), a global provider of regulatory and ethical review services and software to support clinical research, announced that it…

Continue Reading

Cancer Treatment Centers of America selects WCG as IRB

Posted on Dec 16th, 2014

Donald A. Deieso, PhD, chairman and CEO of the WIRB-Copernicus Group (WCG), along with Maurie Markman, MD, president of Cancer Treatment Centers of…

Continue Reading

Cancer Treatment Centers of America chooses WCG as its exclusive IRB, sheds five local hospital IRBs

Posted on Dec 16th, 2014

Donald A. Deieso, PhD, Chairman and CEO, Stuart Horowitz, PhD, MBA, President of Institutions and Institutional Services for the WIRB-Copernicus…

Continue Reading

The Ethics of Experimenting on Yourself

Posted on Oct 24th, 2014

Lindsay McNair, MD, MPH, MSB, Chief Clinical Research Officer of the WIRB-Copernicus Group, is interviewed by Amy Dockser Marcus for The Wall Street…

Continue Reading

People on the Move: Dr. Lindsay McNair

Posted on Oct 3rd, 2014

Lindsay McNair M.D., M.P.H., M.S.B. Recognition Plaque Publication: Philadelphia Business Journal To read this article, please click…

Continue Reading

WIRB-Copernicus Group Appoints Lindsay McNair Chief Medical Officer

Posted on Oct 3rd, 2014

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services and software to support clinical research, has promoted Lindsay…

Continue Reading

Clinical Review Services Firm Names Chief Medical Officer

Posted on Oct 2nd, 2014

WIRB-Copernicus Group, a Princeton-based provider of regulatory and ethical review services and software for clinical research, said Thursday that…

Continue Reading

WIRB Copernicus Group Acquires ePharmaSolutions

Posted on Sep 24th, 2014

WIRB Copernicus Group, after acquiring three IRBs in the past four months, is continuing its spending spree, expanding into a new area with the…

Continue Reading

WCG Looks to Galvanize Northeast Clients with New England IRB Acquisition

Posted on Sep 10th, 2014

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services for clinical research, announced today it has acquired New England…

Continue Reading

eConsent Video Interview at the DIA Annual Meeting

Posted on Sep 9th, 2014

Lindsay McNair, MD, MPH, MSB, Chief Clinical Research Officer of the WIRB-Copernicus Group, is interviewed by Lisa Henderson for Applied Clinical…

Continue Reading

Researchers Fret as Social Media Lift Veil on Drug Trials

Posted on Jul 29th, 2014

Lindsay McNair, MD, MPH, MSB, Chief Clinical Research Officer of the WIRB-Copernicus Group, is interviewed by Amy Dockser Marcus for The Wall Street…

Continue Reading

WIRB-Copernicus Group Acquires Biosafety Consulting Firm Alliance Biosciences

Posted on Jul 24th, 2014

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services for clinical research, has acquired biosafety consultancy Alliance…

Continue Reading

Opinion: Lab Safety Lapses Tell Larger Story

Posted on Jul 22nd, 2014

Recent news recounting the lapses and failures of high-profile laboratory programs serve to highlight the critical role that biorisk management plays…

Continue Reading

WIRB-Copernicus Group Launches Oncology IRB to Meet Challenges of Cancer Research

Posted on May 29th, 2014

The WIRB-Copernicus Group (WCG), a large provider of regulatory and ethical review services for clinical research, has formed WCG Oncology, a new…

Continue Reading

Clinical trials: How drugs get from R&D to your pharmacy

Posted on Jan 12th, 2014

Lindsay McNair, MD, MPH, MSB, Chief Clinical Research Officer of the WIRB-Copernicus Group, is interviewed by Lorraine Rapp and Linda Lowen for "Take…

Continue Reading

Advances in Medicine are Creating New Bioethical Considerations

Posted on Dec 9th, 2013

This contribution to the inaugural Clinical Trials Yearbook is authored by Donald A. Deieso, PhD, Chairman & CEO, WIRB-Copernicus Group. To…

Continue Reading

FDA Warning Letters Drop as Audit Preparation Increases

Posted on Dec 8th, 2013

This article includes an interview of Stuart Horowitz, PhD, MBA, President of Institutions & Institutional Services, WIRB-Copernicus Group, by…

Continue Reading

The Buzz: An Interview with Donald A. Deieso, PhD, WIRB-Copernicus Group

Posted on Dec 7th, 2013

Danny Al-Faruque interviews Donald A. Deieso, PhD, Chairman & CEO, WIRB-Copernicus Group, on behalf of FDAnews.com To read this article in its…

Continue Reading

WIRB-Copernicus Group Announces Appointment of Lindsay McNair, MD, MPH, MSB, to Chief Clinical Research Officer

Posted on Nov 1st, 2013

Applied Clinical Trials announces WIRB-Copernicus Group’s appointment of Lindsay McNair MD, MPH, MSB, to Chief Clinical Research Officer. To…

Continue Reading

Electronic Informed Consent: Will it Increase Patient Knowledge on Trials?

Posted on Aug 13th, 2013

Zachary Brennan interviews Lindsay McNair, MD, MPH, MSB, Chief Clinical Research Officer of the WIRB-Copernicus Group, and Anthony Costello, CEO of…

Continue Reading

Industry Brief: Study Conduct with Dawn Pope, CIP, Copernicus Group IRB

Posted on May 6th, 2013

CenterWatch Weekly interviews Dawn Pope, CIP, Chief Operation Officer, Copernicus Group IRB and announces participation of Stuart Horowitz, PhD, MBA,…

Continue Reading

Insider Insights: An Interview with Dawn Pope, CIP, Copernicus Group IRB

Posted on Apr 1st, 2013

Ronald Rosenberg interviews Dawn Pope, CIP, Chief Operation Officer, Copernicus Group IRB. Publication: CenterWatch Weekly, April 01, 2013, Page…

Continue Reading

20 Innovators Changing the Face of the Clinical Trials Industry: Donald A. Deieso, PhD, WIRB-Copernicus Group

Posted on Apr 1st, 2013

CenterWatch names Donald A. Deieso, PhD, Chairman & CEO, WIRB-Copernicus Group, one of the 20 innovators changing the face of the clinical trials…

Continue Reading

Improving IRBs: A Case Study with Copernicus Group IRB

Posted on Mar 27th, 2013

This contribution to Applied Clinical Trials is authored by Dawn Pope, CIP, Chief Operation Officer, Copernicus Group IRB. To read this article in…

Continue Reading

Do it Right…the First Time

Posted on Mar 1st, 2013

This contribution to Applied Clinical Trials is authored by Dawn Pope, CIP, Chief Operation Officer, Copernicus Group IRB. To read this article in…

Continue Reading

Arsenal Capital Acquires IRBNet, Adding Technical Service Provider to the WIRB-Copernicus Group

Posted on Dec 10th, 2012

CenterWatch announces Arsenal Capital’s acquisition of IRBNet to add to the WIRB-Copernicus Group. Publication: CenterWatch Weekly, December…

Continue Reading

Promoting human protection in drug research on a global scale and the need for uniform standards

Posted on Oct 23rd, 2012

This contribution to Scrip Regulatory Affairs is authored by Nick Slack, MBE, Senior Vice President of Strategic Client Partnerships, WIRB-Copernicus…

Continue Reading

Lean Six Sigma in the Clinical Trial Industry: Two Perspectives

Posted on Oct 9th, 2012

This contribution to Applied Clinical Trials is authored by Dawn Pope, CIP, Chief Operation Officer, Copernicus Group IRB. To read this article in…

Continue Reading

Print Friendly